Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

ExeGi Pharma announces clinical trial of probiotic Visbiome in HIV infection

Aug. 21, 2015

Long-term LATTE results show HIV suppression with two-drug cabotegravir plus rilpivirine regimen

Aug. 20, 2015

Discovery and optimization of novel HIV integrase inhibitors from BMS

Aug. 19, 2015

Pseudo-glycodendrimer blocks HIV transinfection

Aug. 7, 2015

RNA vaccine iHIVARNA-01 enters phase I trial in patients with HIV-1 infection

July 30, 2015

Preliminary phase II results presented for VAC-3S HIV vaccine

July 29, 2015

Prevention of HIV transcription from latency by Tat inhibitor

July 23, 2015

FDA grants breakthrough therapy designation to BMS-663068

July 22, 2015

European Commission approves Evotaz for HIV-1 infection in adults

July 17, 2015

CytoDyn reports evidence of HIV suppression with PRO-140

July 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...